Omniscan (Gadodiamide)

Omniscan is used as a magnetic resonance imaging (MRI) contrast agent to improve the visibility of certain anatomical structures.

• Central nervous system imaging: Enhances detection of lesions and tumors in the brain and spine.
• Vascular imaging: Improves visual assessment of blood vessels and aneurysms.
• Cardiac imaging: Assists in evaluating myocardial perfusion and function.
• Abdominal and pelvic imaging : Provides greater detail for liver and renal structures in the abdomen and pelvis.

• Gadodiamide is a low‑molecular‑weight gadolinium‑based complex that distributes in the extracellular fluid after intravenous injection. Its paramagnetic gadolinium ion shortens T1 relaxation times of nearby water protons, producing a brighter signal on T1‑weighted MRI sequences and thereby enhancing the contrast between normal and pathological tissues.

Adverse reactions to gadodiamide‑based contrast agents are generally uncommon but can occur.

Common Side Effects

• Nausea: Mild, transient feeling of stomach upset.
• Headache: Temporary discomfort often resolving without treatment.
• Injection site discomfort: Minor pain or burning at the infusion site.
• Warmth sensation: Brief feeling of warmth or flushing.

Serious or Rare Side Effects

• Nephrogenic systemic fibrosis (NSF): A rare fibrotic disorder linked to gadolinium exposure in patients with severe renal impairment.
• Anaphylactoid reaction: Acute allergic‑type response that may include hives, swelling or respiratory difficulty.
• Severe hypersensitivity: Potential for bronchospasm or hypotension requiring emergency care.
• Cardiac arrest: Extremely rare but life‑threatening event following administration.

When using Omniscan, clinicians should assess patient risk factors and follow recommended safety measures.

• Renal function assessment: Evaluate glomerular filtration rate before administration in patients with known kidney disease.
• Pregnancy caution: Use only if the diagnostic benefit outweighs potential fetal risk.
• Breastfeeding guidance: Consider discontinuing breastfeeding for a short period after injection.
• Allergy history: Review prior reactions to gadolinium‑based agents or other contrast media.
• Hydration encouragement: Ensure adequate fluid intake post‑procedure to aid renal clearance.
• Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Gadodiamide may interact with other substances that affect renal function or immune response.

Major Interactions (Avoid)

• Nephrotoxic drugs: Concurrent use with high‑dose aminoglycosides or NSAIDs can increase risk of renal injury.
• Iron‑based contrast agents: May interfere with gadolinium clearance and imaging quality.\nModerate Interactions (Monitor Closely):
• Diuretics: May alter fluid balance, affecting gadolinium excretion.
• Immunosuppressants: Potentially modify hypersensitivity risk.
• Beta‑blockers: May mask early signs of anaphylactoid reactions.
• Calcium channel blockers: No direct effect but monitor overall cardiovascular status.